These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Limb-girdle muscular dystrophy: clinical manifestations and detection of preclinical disease. Jackson CE; Strehler DA Pediatrics; 1968 Feb; 41(2):495-502. PubMed ID: 5637795 [No Abstract] [Full Text] [Related]
3. Duchenne muscular dystrophy and idiopathic hyperCKemia in a family causing confusion in genetic counselling. Bushby K; Goodship J; Haggerty D; Heald A; Walls T Am J Med Genet; 1996 Dec; 66(2):237-8. PubMed ID: 8958338 [No Abstract] [Full Text] [Related]
4. [Estimation of the probability of heterozygosity in Duchenne-type progressive muscular dystrophy]. Guízar Vázquez J; Navarrete Cadena C; Rico R; Mora G; Zavala C Bol Med Hosp Infant Mex; 1981; 38(1):23-33. PubMed ID: 7284070 [TBL] [Abstract][Full Text] [Related]
5. [Muscular dystrophy: Duchenne and Becker-Kiener types]. Kuhn E Dtsch Med Wochenschr; 1979 Dec; 104(51):1817-20. PubMed ID: 391521 [No Abstract] [Full Text] [Related]
6. Clinical symptoms in a female carrier of Duchenne muscular dystrophy. Zatz M; Levisky RB; Levy JA; Valente BO; Gianotti M; Frota-Pessoa O J Genet Hum; 1973 Dec; 21(4):297-305. PubMed ID: 4792239 [No Abstract] [Full Text] [Related]
7. Detection of preclinical Duchenne muscular dystrophy and its female carriers. Beckmann R Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671 [No Abstract] [Full Text] [Related]
8. [Screening for elevated creatine kinase activities for the early diagnosis of Duchenne muscular dystrophy]. Beckmann R; Scheuerbrandt G Fortschr Med; 1979 Oct; 97(39):1733-6. PubMed ID: 511067 [TBL] [Abstract][Full Text] [Related]
10. [Identification of the carrier state in the severe recessive X-linked muscular dystrophy (Duchenne type). I. Assay of activated serum creatine kinase activity in serum (author's transl)]. Rotthauwe HW; Kowalewski S Z Kinderheilkd; 1973 Nov; 115(4):333-42. PubMed ID: 4591596 [No Abstract] [Full Text] [Related]
11. Spinal muscular atrophy and probable Duchenne muscular dystrophy occurring separately in closely related Melanesian families in Papua, New Guinea. Scrimgeour EM; Mastaglia FL; Kevau I Am J Med Genet; 1992 Aug; 43(6):1044-5. PubMed ID: 1415334 [No Abstract] [Full Text] [Related]
13. [Biochemical, histological and clinical findings in carriers of Duchenne-type progressive muscular dystrophy]. Moser H; Mumenthaler M; Wiesmann U Schweiz Med Wochenschr; 1971 Apr; 101(15):537-42. PubMed ID: 5576948 [No Abstract] [Full Text] [Related]
14. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy. Nakane K Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757 [No Abstract] [Full Text] [Related]
15. Investigation on healthy individuals from families of patients with Duchenne type muscular dystrophy. Hausmanowa-Petrusewicz I; Prot J; Niebrój-Dobosz I; Emeryk B; Wasowicz B; Slucka C; Hetnarska L; Bendarzewska B; Pucek Z Pol Med J; 1968; 7(1):228-37. PubMed ID: 5652928 [No Abstract] [Full Text] [Related]
16. Early diagnosis and treatment of rapidly developing Duchenne De Boulogne type myopathy (type DDB I). Demos J Am J Phys Med; 1971 Dec; 50(6):271-84. PubMed ID: 5141650 [No Abstract] [Full Text] [Related]
17. Human growth hormone and estrogens in boys with Duchenne muscular dystrophy. Chyatte SB; Rudman D; Patterson JH; Gerron GG; O'Beirne I; Barlow J; Jordan A; Shavin JS Arch Phys Med Rehabil; 1973 Jun; 54(6):248-53. PubMed ID: 4708006 [No Abstract] [Full Text] [Related]
18. [Serum creatine phosphokinase activity in Duchenne-type muscular dystrophy and carriers]. Kato F; Takahashi K Iryo; 1968 Dec; 22(12):1386-91. PubMed ID: 5717705 [No Abstract] [Full Text] [Related]